Sharp Clinical offers a full complement of clinical trial services, including analytical, formulation development, clinical manufacturing and packaging, storage and distribution. Sharp also offers an interactive response technology (IRT) platform which can accommodate simple to complex randomization schemes as well as clinical supply chain management.
During 2018, Sharp Clinical invested $36 million in new dedicated facilities in both the US and the UK and can offer QP services for European distribution. We service every phase of the drug lifecycle from Phase 1 through to commercialization and through our global network of over 30 depots we can distribute to every region of the world. Our highly experienced team will help you optimize every aspect of your clinical trial.
Sharp Clinical Services
2400 Baglyos Circle
Bethlehem, PA 18020
Contact: Joe Scollins
Sharp Clinical UK
Unit 28, Heol Klockner
Heads of the Valleys Ind Est
Rhymney, NP22 5RL
Contact: Scott Forde
Patient enrollment and retention remain a critical variable in clinical trial studies. Increasingly, sponsors are looking to the DTP trial model for certain patient populations, such as the elderly and critically ill. Watch this on-demand webinar and learn how to optimize your distribution chain for direct-to-patient clinical trials.
This webinar highlights how through better planning and early engagement with experienced IRT specialists, you can reduce the risk, time and resources spent on your clinical trial.
As companies are looking to reduce their supplier base and shifting towards more strategic relationships with key suppliers to achieve economies of scale, learn how contract suppliers can benefit from developing strategic partnerships with other vendors and operating as one entity.
IRT professionals can bring together supply chain and clinical team staff for discussions on actual trial needs. Learn how including IRT professionals earlier in the planning phase of clinical trials may result in a better understanding of supply chain needs. This can increase the efficiency of inventory management and lead to unforeseen cost savings over the course of the trial.
Sharp Packaging Services works across the world to create unique commercial and clinical packaging solutions for the pharmaceutical and biotechnology industry. In this video to learn why Sharp Packaging Services has an exceptional global reputation for the design, serialization and production of innovative, cost-effective compliance packaging for even the most complex products.
Sharp Clinical Services provided a solution for a pharma clients that required a new oral formulation of their product. Multiple active ingredients created a complex manufacturing process combined with a requirements of 8 different batches required expertise of Sharp's Analytical and Formulation Development teams.
Following a successful inspection by the MHRA, Sharp can now offer a range of clinical trial and commercial services from the £9.5M facility including primary and secondary packaging with low humidity control, labelling, storage and distribution, QP services as well as controlled drug storage.
Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots and investigative sites.
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution.
Sharp – a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed the first phase in the development of its new USD $23m state-of-the-art facility in Bethlehem, PA.
Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23M state-of-the-art facility in Bethlehem, PA.
Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced an investment of $11 million to increase its global cold storage and syringe assembly capacity in response to market demand.